EXODIAB: Excellence of Diabetes Research in Sweden
141 – 150 of 4142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Mortality risk relationship using standard categorized BMI or knee-height based BMI – does the overweight/lower mortality paradox hold true?
(
- Contribution to journal › Article
-
Mark
”Studenternas aktivism visar en hoppfull strävan.”
2024) In Sydsvenskan(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
(
- Contribution to journal › Article
-
Mark
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
-
Mark
Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies
(
- Contribution to journal › Article
-
Mark
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
2024) In Diabetologia(
- Contribution to journal › Article
-
Mark
Epigenome-wide association study of DNA methylation in maternal blood leukocytes with BMI in pregnancy and gestational weight gain
2024) In International Journal of Obesity(
- Contribution to journal › Article
-
Mark
Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors
(
- Contribution to journal › Article
-
Mark
Significance of understanding the genomics of host-pathogen interaction in limiting antibiotic resistance development : Lessons from COVID-19 pandemic
(
- Contribution to journal › Scientific review
-
Mark
Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19
(
- Contribution to journal › Article